THRX Financial Facts
General and administrative: 7.8MBasic and diluted net loss per share (in dollars per share): -0.37
See Full Income Statement
Notes receivable: 85K
Convertible subordinated notes: 172.5M
See Full Balance Sheet
Theravance Inc. (THRX) Earnings
|
Expand Research on THRX
| Next EPS Date | N/A | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | -19.8% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | -1.9% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 8/31/22 | Q222 | N/A | -$0.29 | N/A | N/A | N/A | N/A | N/A | N/A | ||
10/28/15  |
 |
Q315 | -$0.04 | -$0.03 | -$0.01 | $13.6M | $15.23M | N/A |  | | Details |
| 7/29/15 |
|
Q215 | -$0.07 | -$0.06 | -$0.01 | $10.7M | $10.9M | N/A | | | Details |
| 5/6/15 |
|
Q115 | -$0.09 | N/A | N/A | $6.8M | $7M | N/A | | | Details |
| 2/18/15 |
|
Q414 | -$0.14 | -$0.15 | +$0.01 | $7.3M | $5.42M | N/A | | | Details |
| 10/30/14 |
|
Q314 | -$0.19 | -$0.14 | -$0.05 | $999K | $6.3M | N/A | | | Details |
| 8/6/14 |
|
Q214 | -$0.18 | -$0.44 | +$0.26 | $934K | $4.39M | N/A | | | Details |
| 5/6/14 |
|
Q114 | -$0.62 | -$0.53 | -$0.09 | $165K | $4.52M | N/A | | | Details |
